Ji Ji, Lu Min, Guo Shulan, Xiang Bo, Wu Weiwei, Li Yang, Jiao Xiaoyan, Ji Jun, Ding Xiaoqiang, Yu Xiaofang, Yu Xiaofang
Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.
Shanghai Medical Center of Kidney, Shanghai, China.
Am J Nephrol. 2025;56(4):433-444. doi: 10.1159/000543622. Epub 2025 Feb 25.
Different uremic solutes have varying degrees of clearances owing to different chemical properties and the pathological and physiological changes in the kidneys and peritoneum.
The 5-year time profiles of renal, peritoneal, and total clearances of creatinine, urea nitrogen (UN), uric acid (UA), trimethylamine
Peritoneal clearances of creatinine, UN, UA, and phosphate increased over time, while the peritoneal clearance of IL-6 showed a downward trend. The peritoneal clearances of TMAO, β2-MG, IS, and PCS did not change significantly. Patients in early start group showed a lower level of variation and a higher average of renal clearances. IPD patients had a higher level of total clearances of uremic solutes than full-dose PD patients in the first 3 years after PD initiation.
In a long-term follow-up period, the peritoneal clearance of water-soluble small solutes increased over time, but that of protein-bound toxins and middle molecules did not. Initiating PD when residual kidney function remains at a relatively high level and performing IPD may better improve the efficiency of PD and help preserve the renal clearances of uremic solutes.
由于不同的化学性质以及肾脏和腹膜的病理生理变化,不同的尿毒症溶质清除率各不相同。
对64例腹膜透析(PD)患者的肌酐、尿素氮(UN)、尿酸(UA)、三甲胺氮氧化物(TMAO)、磷酸盐、β2-微球蛋白(β2-MG)、白细胞介素-6(IL-6)、硫酸吲哚酚(IS)和对甲酚硫酸盐(PCS)的肾脏清除率、腹膜清除率和总清除率进行了5年的时间分析。根据基线估计肾小球滤过率将患者分为早期开始组和晚期开始组,以研究透析开始时间对尿毒症溶质清除率的影响。患者还被分为递增腹膜透析(IPD)组和全剂量PD组,以研究PD策略对尿毒症溶质清除率的影响。
肌酐、UN、UA和磷酸盐的腹膜清除率随时间增加,而IL-6的腹膜清除率呈下降趋势。TMAO、β2-MG、IS和PCS的腹膜清除率无显著变化。早期开始组患者的变化水平较低,肾脏清除率平均值较高。IPD患者在PD开始后的前3年中,尿毒症溶质的总清除率高于全剂量PD患者。
在长期随访期间,水溶性小溶质的腹膜清除率随时间增加,但与蛋白结合的毒素和中分子的腹膜清除率没有增加。当残余肾功能保持在相对较高水平时开始PD并进行IPD可能会更好地提高PD效率,并有助于保留尿毒症溶质的肾脏清除率。